Quick Takeaways
- Panacea Innovation Ltd filed SCHEDULE 13G/A for Marinus Pharmaceuticals, Inc. Common Stock (MRNS).
- Disclosed ownership: 0%.
- Date of event: 31 Dec 2024.
Panacea Innovation Ltd - 31 Dec 2024 SCHEDULE 13G/A Report for Marinus Pharmaceuticals, Inc. Common Stock (MRNS)
- Filing Manager
- Panacea Innovation Ltd
- Reporting Manager
- Panacea Venture Healthcare Fund II, L.P.
- Symbol
- MRNS
- Disclosed Ownership
- 0 shares
- Ownership
- 0%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Feb 2025, 16:30:03 UTC
- Date of event
- 31 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Panacea Innovation Ltd disclosed 0% ownership in Marinus Pharmaceuticals, Inc. Common Stock (MRNS) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Feb 2025, 16:30.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Panacea Venture Healthcare Fund II, L.P. | 0% | 0 | 0 | 0 | By: Panacea Venture Healthcare Fund II GP Company, Ltd., its general partner, By: Panacea Innovation Limited, its sole owner, /s/ James Huang | James Huang, Founding Managing Partner | |
| Panacea Venture Healthcare Fund II GP Company, Ltd. | 0% | 0 | 0 | 0 | By: Panacea Innovation Limited, its sole owner, /s/ James Huang | James Huang, Founding Managing Partner | |
| Panacea Innovation Limited | 0% | 0 | 0 | 0 | /s/ James Huang | James Huang, Founding Managing Partner | |
| James Huang | 0% | 0 | 0 | 0 | /s/ James Huang | James Huang |